Key terms

About MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MASI news

Apr 15 5:15am ET Masimo upgraded to Buy from Hold at Stifel Apr 15 4:55am ET Buy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal Growth Apr 08 2:14am ET Apple Stock (NASDAQ:APPL) News: Here’s What Investors Need to Know Apr 02 5:06am ET Buy Rating Affirmed for Masimo Amid Strategic Split and Enhanced Profitability Outlook Apr 01 8:27am ET Masimo responds to Politan’s nominations, ‘refutes Politan’s false claims’ Mar 25 2:06pm ET CEO tells WSJ Masimo may look at joint venture for consumer spilt Mar 25 9:44am ET Tesla downgraded, Disney upgraded: Wall Street’s top analyst calls Mar 25 7:29am ET Masimo price target raised to $166 from $145 at BTIG Mar 25 7:17am ET Masimo shareholder Politan nominates two independent candidates to board Mar 25 6:50am ET Analysts Conflicted on These Healthcare Names: Masimo (MASI), ImmunityBio (IBRX) and Madrigal Pharmaceuticals (MDGL) Mar 25 6:48am ET Masimo price target raised to $148 from $125 at Stifel Mar 25 6:40am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Amedisys (AMED) and Masimo (MASI) Mar 25 5:30am ET Analysts Offer Insights on Healthcare Companies: Esperion (ESPR) and Masimo (MASI) Mar 25 5:12am ET Masimo upgraded to Overweight from Equal Weight at Wells Fargo Mar 24 7:21pm ET Activist Politan planning second proxy battle at Masimo, WSJ reports Mar 23 10:41am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Mar 22 4:13pm ET Masimo Corp Contemplates Spinning Off Consumer Business Mar 22 4:07pm ET Masimo board approves evaluation of separation of consumer business Feb 28 7:23am ET Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ) Feb 28 5:28am ET Hold Rating on Masimo Amid Market Transition and Legal Uncertainties Feb 28 5:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK), Alphatec Holdings (ATEC) and Masimo (MASI) Feb 27 4:36pm ET Masimo Corp: Financial Results Review and 2024 Outlook Feb 27 4:08pm ET Masimo sees FY24 adjusted EPS $3.44-$3.60, consensus $3.32 Feb 27 4:07pm ET Masimo sees Q1 adjusted EPS 67c-74c, consensus 73c Feb 27 4:07pm ET Masimo reports Q4 adjusted EPS $1.25, consensus 87c Feb 26 7:55am ET Masimo (MASI) Gets a Hold from Piper Sandler Feb 26 7:33am ET Masimo price target raised to $117 from $70 at Piper Sandler Feb 15 9:12am ET Masimo Corp Announces Board Reshuffle and Director Resignation Feb 07 5:29am ET Hold Ratings Justified by Mixed Financial Signals and Market Challenges Feb 01 1:28pm ET What Wall Street experts are saying about Apple ahead of earnings Feb 01 1:28pm ET What Wall Street experts are saying about Apple ahead of earnings

MASI Financials

1-year income & revenue

Key terms

MASI Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MASI Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms